Secor Capital Advisors’s Amgen AMGN Stock Holding History

Secor Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,052	Closed	-$1.2M	–	489
2018 Q1	$1.2M	Buy	+7,052	New	+$1.29M	0.1%	267
2017 Q3	–	Sell	-18,255	Closed	-$3.14M	–	429
2017 Q2	$3.14M	Sell	18,255 -382	-2%	-$62.1K	0.29%	111
2017 Q1	$3.06M	Buy	+18,637	New	+$3.1M	0.33%	94
2015 Q4	–	Sell	-3,483	Closed	-$482K	–	527
2015 Q3	$482K	Buy	3,483 +86	+3%	+$13.6K	0.15%	244
2015 Q2	$522K	Buy	+3,397	New	+$544K	0.19%	193
2014 Q4	–	Sell	-3,409	Closed	-$479K	–	383
2014 Q3	$479K	Buy	+3,409	New	+$445K	0.27%	127

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Secor Capital Advisors's AMGN Position: Q2 2018 in Review

Secor Capital Advisors sold out of Amgen (AMGN) in Q2 2018, closing a stake of 7,052 shares — an estimated $1.2M sold.

Secor Capital Advisors first reported a position in AMGN in Q3 2014 and held it in 6 quarters. The position peaked at $3.14M in Q2 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

Secor Capital Advisors reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
Secor Capital Advisors sold 7,052 Amgen shares in Q2 2018, an estimated $1.2M.
Secor Capital Advisors first reported a position in Amgen in Q3 2014 and held it in 6 quarters.
Secor Capital Advisors's Amgen position peaked at $3.14M in Q2 2017.
1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Secor Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.